Manufacturer record

Lark Laboratories (India) Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Lark Laboratories (India) Ltd (Rajasthan) were declared Not of Standard Quality between February 2019 and December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: VSR1-05, Valsartan Tablets IP 80mg(Valsalar- 80 Tablets) (exp Mar 2026). CDTL Chennai (CDSCO lab) found it not of standard quality: The Sample does not conform to IP Standards with respect to Test for Dissolution only. Listed in the December 2024 alert.

Records by type

5 records linked to Lark Laboratories (India) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2019 to Dec 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2019
4
Products affected
Dissolution
Most common failure
Dec 2024
Latest alert

Flagged batches per year

2019 · 12022 · 12024 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Valsartan Tablets IP 80mg(Valsalar- 80 Tablets) Batch VSR1-05Mfg Apr 2024 · Exp Mar 2026 The Sample does not conform to IP Standards with respect to Test for Dissolution onlyDissolution CDTL ChennaiCDSCO lab Dec 2024
Symolar-Forte Batch SFT5-61Mfg Apr 2024 · Exp Sep 2025 sample does not conform to Schedule V of D&C Act with respect to general requirement for tabletsOther DTL ChennaiState lab Nov 2024
Betamethasone Sodium Phosphate Tablets I.P. (Betalar-S) Batch BT3-50Mfg Dec 2023 · Exp Nov 2025 DescriptionDescription CDL KolkataCDSCO lab Mar 2024
PARACETAMOL TABLETS IP (Larkin) Batch E-23Mfg Dec 2021 · Exp Nov 2024 DissolutionDissolution RDTL GuwahatiState lab Sep 2022
Paracetamol Tablets I.P. (LARKIN) Batch E-10Mfg Aug 2017 · Exp Jul 2019 DissolutionDissolution Drugs Control Department, MizoramCDSCO lab Feb 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.